Photo Galleries

(Image: Getty/Rawpixel)

Hired and Retired: Transitions at the top

By Ben Hargreaves

In a significant move at the larger end of the biopharma world, AstraZeneca’s global VP of cardiovascular, renal and metabolism made the move to Novo Nordisk to head up its biopharm unit.

(Image: Getty/Phototechno)

Hired and Retired: Big pharma to biotech trend continues

By Ben Hargreaves

As the stream of executives flowing from large pharma companies to smaller biotechs builds into a torrent, another month has passed with a number of significant switches. Notably, two former Genentech employees, responsible for work on some of its bestselling...

Inside Celltrion: a biosimilar success story built on landfill

Dispatches from Korea

Inside Celltrion: a biosimilar success story built on landfill

By Dan Stanton

Ambition, hard work and a focus on quality has made Celltrion the ‘pioneers of the mAb biosimilar industry,’ the firm told Biopharma-Reporter during a tour of its biomanufacturing site in Songdo, Korea.

BIO 2014: Photographs from inside the conference

BIO 2014: Photographs from inside the conference

By Zachary Brennan

Former Secretary of State and First Lady Hillary Clinton popped in for a long interview during one of the keynote luncheons to discuss all sorts of different topics with a BIO executive. The luncheon nicely complimented the international theme of the...

Taking a trip down to the 'Animal (Bio) Farm'

EDITOR'S BLOG

Taking a trip down to the 'Animal (Bio) Farm'

By Dan Stanton

Lab rats are not the only animals to play a role in bologics development as Biopharma-Reporter.com discovered when it donned its wellington boots and took a wonder down to the pharm...

Octapharma invites us 'truly human' Factor VIII plant

Octapharma invites BPR to 'truly human' Factor VIII plant

By Gareth Macdonald

Last year Octapharma filed the world’s first ‘truly human’ recombinant Factor VIII clotting protein for EMA review and invited BioPharma-Reporter.com to visit the Swedish site where it makes the haemophilia treatment using HEK cells.